SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Giedraitis Vilmantas) "

Sökning: WFRF:(Giedraitis Vilmantas)

  • Resultat 21-30 av 114
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
21.
  • Flannick, Jason, et al. (författare)
  • Data Descriptor : Sequence data and association statistics from 12,940 type 2 diabetes cases and controls
  • 2017
  • Ingår i: Scientific Data. - : Springer Science and Business Media LLC. - 2052-4463. ; 4
  • Tidskriftsartikel (refereegranskat)abstract
    • To investigate the genetic basis of type 2 diabetes (T2D) to high resolution, the GoT2D and T2D-GENES consortia catalogued variation from whole-genome sequencing of 2,657 European individuals and exome sequencing of 12,940 individuals of multiple ancestries. Over 27M SNPs, indels, and structural variants were identified, including 99% of low-frequency (minor allele frequency [MAF] 0.1-5%) non-coding variants in the whole-genome sequenced individuals and 99.7% of low-frequency coding variants in the whole-exome sequenced individuals. Each variant was tested for association with T2D in the sequenced individuals, and, to increase power, most were tested in larger numbers of individuals (> 80% of low-frequency coding variants in similar to ~82 K Europeans via the exome chip, and similar to ~90% of low-frequency non-coding variants in similar to ~44 K Europeans via genotype imputation). The variants, genotypes, and association statistics from these analyses provide the largest reference to date of human genetic information relevant to T2D, for use in activities such as T2D-focused genotype imputation, functional characterization of variants or genes, and other novel analyses to detect associations between sequence variation and T2D.
  •  
22.
  • Folkersen, Lasse, et al. (författare)
  • Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.
  • 2020
  • Ingår i: Nature metabolism. - : Springer Science and Business Media LLC. - 2522-5812. ; 2:10, s. 1135-1148
  • Tidskriftsartikel (refereegranskat)abstract
    • Circulating proteins are vital in human health and disease and are frequently used as biomarkers for clinical decision-making or as targets for pharmacological intervention. Here, we map and replicate protein quantitative trait loci (pQTL) for 90 cardiovascular proteins in over 30,000 individuals, resulting in 451 pQTLs for 85 proteins. For each protein, we further perform pathway mapping to obtain trans-pQTL gene and regulatory designations. We substantiate these regulatory findings with orthogonal evidence for trans-pQTLs using mouse knockdown experiments (ABCA1 and TRIB1) and clinical trial results (chemokine receptors CCR2 and CCR5), with consistent regulation. Finally, we evaluate known drug targets, and suggest new target candidates or repositioning opportunities using Mendelian randomization. This identifies 11 proteins with causal evidence of involvement in human disease that have not previously been targeted, including EGF, IL-16, PAPPA, SPON1, F3, ADM, CASP-8, CHI3L1, CXCL16, GDF15 and MMP-12. Taken together, these findings demonstrate the utility of large-scale mapping of the genetics of the proteome and provide a resource for future precision studies of circulating proteins in human health.
  •  
23.
  • Folkersen, Lasse, et al. (författare)
  • Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease
  • 2017
  • Ingår i: PLOS Genetics. - : PUBLIC LIBRARY SCIENCE. - 1553-7390 .- 1553-7404. ; 13:4
  • Tidskriftsartikel (refereegranskat)abstract
    • Recent advances in highly multiplexed immunoassays have allowed systematic large-scale measurement of hundreds of plasma proteins in large cohort studies. In combination with genotyping, such studies offer the prospect to 1) identify mechanisms involved with regulation of protein expression in plasma, and 2) determine whether the plasma proteins are likely to be causally implicated in disease. We report here the results of genome-wide association (GWA) studies of 83 proteins considered relevant to cardiovascular disease (CVD), measured in 3,394 individuals with multiple CVD risk factors. We identified 79 genome-wide significant (p<5e-8) association signals, 55 of which replicated at P<0.0007 in separate validation studies (n = 2,639 individuals). Using automated text mining, manual curation, and network-based methods incorporating information on expression quantitative trait loci (eQTL), we propose plausible causal mechanisms for 25 trans-acting loci, including a potential post-translational regulation of stem cell factor by matrix metalloproteinase 9 and receptor-ligand pairs such as RANK-RANK ligand. Using public GWA study data, we further evaluate all 79 loci for their causal effect on coronary artery disease, and highlight several potentially causal associations. Overall, a majority of the plasma proteins studied showed evidence of regulation at the genetic level. Our results enable future studies of the causal architecture of human disease, which in turn should aid discovery of new drug targets.
  •  
24.
  • Forsberg, Lars A., et al. (författare)
  • Age-related somatic structural changes in the nuclear genome of human blood cells
  • 2012
  • Ingår i: American Journal of Human Genetics. - : Elsevier BV. - 0002-9297 .- 1537-6605. ; 90:2, s. 217-228
  • Tidskriftsartikel (refereegranskat)abstract
    • Structural variations are among the most frequent interindividual genetic differences in the human genome. The frequency and distribution of de novo somatic structural variants in normal cells is, however, poorly explored. Using age-stratified cohorts of 318 monozygotic (MZ) twins and 296 single-born subjects, we describe age-related accumulation of copy-number variation in the nuclear genomes in vivo and frequency changes for both megabase- and kilobase-range variants. Megabase-range aberrations were found in 3.4% (9 of 264) of subjects ≥60 years old; these subjects included 78 MZ twin pairs and 108 single-born individuals. No such findings were observed in 81 MZ pairs or 180 single-born subjects who were ≤55 years old. Recurrent region- and gene-specific mutations, mostly deletions, were observed. Longitudinal analyses of 43 subjects whose data were collected 7-19 years apart suggest considerable variation in the rate of accumulation of clones carrying structural changes. Furthermore, the longitudinal analysis of individuals with structural aberrations suggests that there is a natural self-removal of aberrant cell clones from peripheral blood. In three healthy subjects, we detected somatic aberrations characteristic of patients with myelodysplastic syndrome. The recurrent rearrangements uncovered here are candidates for common age-related defects in human blood cells. We anticipate that extension of these results will allow determination of the genetic age of different somatic-cell lineages and estimation of possible individual differences between genetic and chronological age. Our work might also help to explain the cause of an age-related reduction in the number of cell clones in the blood; such a reduction is one of the hallmarks of immunosenescence.
  •  
25.
  • Forsberg, Lars A., 1974-, et al. (författare)
  • Mosaic loss of chromosome Y in leukocytes matters
  • 2019
  • Ingår i: Nature Genetics. - : Springer Science and Business Media LLC. - 1061-4036 .- 1546-1718. ; 51:1, s. 4-7
  • Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)
  •  
26.
  • Forsberg, Lars A., et al. (författare)
  • Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer
  • 2014
  • Ingår i: Nature Genetics. - : Springer Science and Business Media LLC. - 1061-4036 .- 1546-1718. ; 46:6, s. 624-628
  • Tidskriftsartikel (refereegranskat)abstract
    • Incidence and mortality for sex-unspecific cancers are higher among men, a fact that is largely unexplained(1,2). Furthermore, age-related loss of chromosome Y (LOY) is frequent in normal hematopoietic cells(3,4), but the phenotypic consequences of LOY have been elusive(5-10). From analysis of 1,153 elderly men, we report that LOY in peripheral blood was associated with risks of all-cause mortality (hazards ratio (HR) = 1.91, 95% confidence interval (CI) = 1.17-3.13; 637 events) and non-hematological cancer mortality (HR = 3.62, 95% CI = 1.56-8.41; 132 events). LOY affected at least 8.2% of the subjects in this cohort, and median survival times among men with LOY were 5.5 years shorter. Association of LOY with risk of all-cause mortality was validated in an independent cohort (HR = 3.66) in which 20.5% of subjects showed LOY. These results illustrate the impact of post-zygotic mosaicism on disease risk, could explain why males are more frequently affected by cancer and suggest that chromosome Y is important in processes beyond sex determination. LOY in blood could become a predictive biomarker of male carcinogenesis.
  •  
27.
  • Fuchsberger, Christian, et al. (författare)
  • The genetic architecture of type 2 diabetes
  • 2016
  • Ingår i: Nature. - : Springer Science and Business Media LLC. - 0028-0836 .- 1476-4687. ; 536:7614, s. 41-47
  • Tidskriftsartikel (refereegranskat)abstract
    • The genetic architecture of common traits, including the number, frequency, and effect sizes of inherited variants that contribute to individual risk, has been long debated. Genome-wide association studies have identified scores of common variants associated with type 2 diabetes, but in aggregate, these explain only a fraction of the heritability of this disease. Here, to test the hypothesis that lower-frequency variants explain much of the remainder, the GoT2D and T2D-GENES consortia performed whole-genome sequencing in 2,657 European individuals with and without diabetes, and exome sequencing in 12,940 individuals from five ancestry groups. To increase statistical power, we expanded the sample size via genotyping and imputation in a further 111,548 subjects. Variants associated with type 2 diabetes after sequencing were overwhelmingly common and most fell within regions previously identified by genome-wide association studies. Comprehensive enumeration of sequence variation is necessary to identify functional alleles that provide important clues to disease pathophysiology, but large-scale sequencing does not support the idea that lower-frequency variants have a major role in predisposition to type 2 diabetes.
  •  
28.
  • Giedraitis, Vilmantas, et al. (författare)
  • CALHM1 P86L polymorphism does not alter amyloid-beta or tau in cerebrospinal fluid
  • 2010
  • Ingår i: Neuroscience Letters. - : Elsevier BV. - 0304-3940 .- 1872-7972. ; 469:2, s. 265-267
  • Tidskriftsartikel (refereegranskat)abstract
    • Recently, the P86L alteration in CALHM1 (calcium homeostasis modulator-1) was reported to be associated with Alzheimer's disease (AD). Moreover, the risk allele increased amyloid-beta (A beta) levels in conditioned media from cultured cells. Therefore, we hypothesized that CALHM1 P86L may modulate A beta or tau levels in cerebrospinal fluid (CSF). Nearly 200 individuals with AD or other cognitive disorders were included for CSF analysis and CALHM1 genotyping. No significant differences in CSF levels of A beta 42, tau or phospho-tau were found across the various CALHM1 genotypes. In conclusion, we found no evidence that CALHM1 P86L is associated with altered CSF levels of the investigated AD biomarkers.
  •  
29.
  • Giedraitis, Vilmantas (författare)
  • Candidate gene analyses and genome-wide screens in multiple sclerosis
  • 2002
  • Doktorsavhandling (övrigt vetenskapligt/konstnärligt)abstract
    • Specific disease causing mutations have been identified for many disorders. Most of these disorders are of Mendelian origin and there have been very few successful attempts in the genetic dissection of complex traits. Multiple sclerosis (MS) is a chronic immune-mediated demyelinating disease of the central nervous system with clear influence of both environmental and genetic factors. It is genetically complex, however to date the only genetic region clearly demonstrated to be involved in MS is the major histocompatibility complex. In our studies we have analyzed two NIS candidate genes as well as tried to identify chromosomal regions harboring MS susceptibility genes by genome-wide screens. Alteration in interferon-gamma (IFN-gamma) production has been found in several diseases including multiple sclerosis. Such alterations could theoretically be caused by polymorphisms in the gene. We screened the IFN-gamma gene promoter and part of the first intron for possible mutations by sequencing. We identified a C to T substitution in the IFN-gamma promoter at position -333. Screening for this mutation by sequence specific PCR in 214 MS patients and 164 controls identified two patients, both heterozygous, but no controls with this mutation. The IFN-gamma gene seems to be rather conserved and most probably changes in IFN-gamma expression are due to variations in transcription factor activity, rather than gene polymorphisms. One of the factors influencing IFN-gamma production is interleukin-18 (IL-18). We cloned the human IL-18 promoter and screened it for possible polymorphisms. Five single nucleotide polymorphisms were identified. Three combinations of these polymorphisms were observed in the Swedish population and were analyzed for activity. All alleles had clear promoter activity, which increased after stimulation with PMA/ionomicin. There were no significant differences in promoter activity between alleles before stimulation, but after stimulation, one of the alleles had clearly lower activity than the others. Measurement of IL-18 and IFN-gamma production by RT-PCR showed slightly higher expression of IL-18 in individuals homozygous for the most frequent allele. Two polymorphisms, identifying promoter alleles, were analyzed by sequence specific PCR in MS patients and healthy controls, however no significant differences were found. In the next tree studies we have used isolated and localized Swedish populations to screen the genome for NIS susceptibility regions. By haplotype sharing analysis we studied a genetically isolated population from Överkalix in Northern Sweden, where a high incidence of MS was previously reported. Genealogical analysis had shown that 19 MS patients available for our study, originated from a single common ancestral couple in the eighteenth century. Five affected individuals were selected for an initial genomic screen with 390 micro-satellite markers. Shared haplotypes identified in these patients were analyzed in other MS patients and healthy relatives. A conserved haplotype spanning 10 cM was identified on 17p11. Surprisingly, DR-typing revealed no significant sharing of the 14LA region. In the next study we extended the analysis of the Överkalix MS pedigrees and performed a genomewide screen in all available families. We analyzed data by haplotype based transmission disequilibrium test (TDT) and likelihood-ratio test for linkage disequilibrium. Four regions showed significant p-values in both tests. By a haplotype-based TDT analysis, several additional regions were identified. The two most interesting loci were in chromosomes 10p13 and 17p11, being identified by both approaches and corresponding to loci identified in other studies. We also performed a genome-wide screen with 834 microsatellite marker in a family material collected in Värmland county of Sweden, consisting of 54 MS patients and 114 healthy family members. A group of families were possible to track back to common ancestors in the 17th century. We used single marker and haplotype based TDT analysis and nonparametric linkage analysis to analyze data. Regions on chromosomes 2q21-33, 6p25-23, 6q25-27, 14q24-31 and 17q22 were found to be in transmission disequilibrium with MS. Most interesting region was 14q24-31, where several dimarker haplotypes were in transmission disequilibrium in the affected individuals. One marker in this region was also positive in single marker TDT.
  •  
30.
  • Giedraitis, Vilmantas, et al. (författare)
  • Genetic analysis of Alzheimer's disease in the Uppsala Longitudinal Study of Adult Men
  • 2009
  • Ingår i: Dementia and Geriatric Cognitive Disorders. - : S. Karger AG. - 1420-8008 .- 1421-9824. ; 27:1, s. 59-68
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND/AIMS: Genetic factors influencing common complex conditions have proven difficult to identify, and data from numerous investigations have provided incomplete conclusions as to the identity of these genes. Here we aimed to identify susceptibility genes for late-onset Alzheimer's disease (AD). METHODS: The case-control analysis included samples from 86 AD patients and 404 cognitively healthy controls selected from the Uppsala Longitudinal Study of Adult Men (ULSAM). In the incidence analysis, all 1,088 genotyped ULSAM participants were included. DNA samples from ULSAM participants were analyzed for 2,578 single nucleotide polymorphisms (SNP) within 368 genes. The selection of genes tested for association to AD within this cohort was based on genes previously implicated in conditions with relevance to ULSAM, such as dementia, cardiovascular disease, diabetes and metabolic syndrome, osteoporosis, and cancer. RESULTS/CONCLUSION: Association analysis revealed 82 genes containing at least 1 significant SNP at p < 0.05 with association to AD. Only 20 genes remained significant after a permutation test to correct for multiple comparisons within individual genes. Using publicly available data from 2 genome-wide association (GWA) studies and linkage disequilibrium data from HapMap, we attempted to replicate the AD association identified in ULSAM. In addition to apolipoprotein E, we were able to replicate 5 other genes in both GWA studies at p < 0.05.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 21-30 av 114
Typ av publikation
tidskriftsartikel (102)
konferensbidrag (5)
annan publikation (4)
doktorsavhandling (3)
Typ av innehåll
refereegranskat (101)
övrigt vetenskapligt/konstnärligt (13)
Författare/redaktör
Giedraitis, Vilmanta ... (113)
Ingelsson, Martin (53)
Lind, Lars (47)
Lannfelt, Lars (40)
Morris, Andrew P. (24)
Kilander, Lena (23)
visa fler...
Ingelsson, Erik, 197 ... (23)
Lindgren, Cecilia M. (22)
Ingelsson, Erik (21)
Mahajan, Anubha (18)
Salomaa, Veikko (17)
Loos, Ruth J F (17)
Gieger, Christian (15)
Peters, Annette (15)
Amouyel, Philippe (15)
Wareham, Nicholas J. (14)
Laakso, Markku (14)
McCarthy, Mark I (14)
Langenberg, Claudia (14)
Boehnke, Michael (14)
Strauch, Konstantin (14)
Metspalu, Andres (14)
Perola, Markus (13)
Kuusisto, Johanna (13)
Pedersen, Nancy L (13)
Scott, Robert A (13)
Tuomilehto, Jaakko (13)
Sundström, Johan (13)
Esko, Tõnu (13)
Stefansson, Kari (12)
Rotter, Jerome I. (12)
Åberg, Anna Cristina (12)
Gustafsson, Stefan (12)
Palmer, Colin N. A. (12)
Uitterlinden, André ... (12)
Hayward, Caroline (12)
Franco, Oscar H. (12)
Taylor, Kent D. (12)
Ärnlöv, Johan, 1970- (11)
Groop, Leif (11)
van Duijn, Cornelia ... (11)
Mohlke, Karen L (11)
Thorleifsson, Gudmar (11)
Samani, Nilesh J. (11)
Luan, Jian'an (11)
Morris, Andrew D (11)
Gudnason, Vilmundur (11)
Zeggini, Eleftheria (11)
Frayling, Timothy M (11)
Jukema, J. Wouter (11)
visa färre...
Lärosäte
Uppsala universitet (107)
Karolinska Institutet (51)
Högskolan Dalarna (34)
Lunds universitet (28)
Göteborgs universitet (21)
Umeå universitet (21)
visa fler...
Stockholms universitet (10)
Linköpings universitet (3)
Kungliga Tekniska Högskolan (2)
Högskolan i Gävle (2)
Örebro universitet (2)
Jönköping University (2)
Södertörns högskola (2)
Gymnastik- och idrottshögskolan (2)
Handelshögskolan i Stockholm (1)
Mittuniversitetet (1)
Sveriges Lantbruksuniversitet (1)
visa färre...
Språk
Engelska (114)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (99)
Naturvetenskap (11)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy